Su Mon Thwe

Su Mon Thwe

Auto-generated profile, based on publicly available information

Su Mon Thwe

Organization name withheld for security reasons, Berkeley, CA, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2026 in Conflict and Health
Verified
Journal Article
Open access
ARAnu Ramachandran
Anu Ramachandran
STSu Mon Thwe
Su Mon Thwe
CWCho Zin Win
Cho Zin Win
NHNay Lynn Htet
Nay Lynn Htet
SMSaw Kyaw Myint
Saw Kyaw Myint
PPParveen Parmar
Parveen Parmar
Background: Cardiovascular disease (CVD) is a leading cause of death in low-income countries and those affected by armed conflict, including Myanmar. Community health worker interventions can effectively address CVD risk factors in low-income countries but have not been tested among displaced populations in active conflict zones. Objectives: We conducted a feasibility study of a village health worker (VHW) care model to identify individuals at high CVD risk and deliver care in conflict-affected regions of Karen State, Myanmar. This study was conducted by an international non-governmental organization collaborating with a regional local health organization. Methods: Following a village census, trained VHWs and medics screened individuals age ≥ 40 for CVD risk factors in three villages. Eligible individuals had HTN, diabetes, calculated CVD risk > 10%, or history of heart attack or stroke, confirmed during a second visit 1–2 weeks later. VHWs visited households every 3–6 weeks for 2 months to monitor blood pressure, glucose, medication adherence/side effects, and deliver medic-prescribed medications. Feasibility evaluation centered on reach, adoption, and acceptability. Outcomes included CVD risk factor prevalence, recruitment and retention, medication initiation/adherence, changes in hypertension control, and adverse outcomes. VHW and medic focus group discussions and study participant interviews were conducted. Results: CVD teams screened 294 individuals, conducted confirmatory visits with 132, enrolled all 97 eligible participants, and completed two home visits with 94 patients. Several prescription errors were made, halting medication initiation; root cause analysis identified opportunities to improve pre-testing of electronic tools and strengthen clinician CVD training. The proportion of eligible participants receiving antihypertensive or statin medications increased from 23% to 56%. Among those with HTN, the proportion achieving blood pressure control < 140/90 mmHg increased from 22.9% to 65.7%. Qualitative assessment revealed support for the care model and opportunities to improve training and streamline clinical protocols. Conclusions: Our study suggests a VHW care model for CVD in remote villages in Myanmar experiencing armed conflict is feasible and can increase medication access. Opportunities exist to simplify CVD treatment guidelines and augment training and support of local providers. Findings informed a cluster randomized controlled trial to test the impact of a modified VHW care model on medication adherence, CVD risk, and cost. Trial registration: ClinicalTrials.gov, NCT06819839, retrospectively registered 27 October 2024.

14 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
STSu Mon Thwe
Su Mon Thwe
NMNan Ei Mon Myint
Nan Ei Mon Myint
RGRavi Goyal
Ravi Goyal
ZWZin Mar Win
Zin Mar Win
MLMichael Long
Michael Long
ARAdam Kimball Richards
Adam Kimball Richards
BackgroundCardiovascular disease (CVD) is the leading cause of death in many conflict-affected countries including Myanmar. Humanitarian health systems lack evidence of effective and efficient strategies to achieve high coverage of medications proven to reduce CVD risk among forcibly displaced populations in rural areas. This manuscript describes the rationale and design of a cluster randomized controlled trial (cRCT) to test the impact of an integrated village health worker (VHW) care model on medication adherence and costs, among individuals with CVD risk factors living in areas of active armed conflict in eastern Myanmar.MethodsThe hybrid effectiveness-implementation type 1 study centers on a cRCT that randomizes thirteen villages in rural Karen state to intervention and control groups. In intervention villages, mobile teams screen residents ≥40 years old for elevated CVD risk, medics initiate treatment with statins and anti-hypertensive medications, supported by a mobile clinical decision tool, and VHWs conduct monthly home visits to monitor blood pressure, adherence and side effects, and deliver medications. Control village residents receive usual facility-based care. The primary outcome is medication adherence; secondary outcomes include systolic blood pressure and predicted 10-year CVD risk. The study also evaluates the reach, acceptability, perceived sustainability and equity impacts of the intervention using the RE-AIM framework, and distributional cost-effective analysis.DiscussionThis cRCT tests an innovative community-based care delivery model to strengthen cardiovascular disease management for villagers experiencing armed conflict. The study newly employs simulation-based power analysis, health equity metrics, implementation science and cost-effectiveness analysis in a humanitarian emergency.